Cargando…
Norborn-2-en-7-ones as physiologically-triggered carbon monoxide-releasing prodrugs
A prodrug strategy for the release of the gasotransmitter CO at physiological pH, based upon 3a-bromo-norborn-2-en-7-one Diels–Alder cycloadducts of 2-bromomaleimides and 2,5-dimethyl-3,4-diphenylcyclopentadienone has been developed. Examples possessing protonated amine and diamine groups showed goo...
Autores principales: | Kueh, Jui Thiang Brian, Stanley, Nathan J., Hewitt, Russell J., Woods, Laura M., Larsen, Lesley, Harrison, Joanne C., Rennison, David, Brimble, Margaret A., Sammut, Ivan A., Larsen, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609517/ https://www.ncbi.nlm.nih.gov/pubmed/28970925 http://dx.doi.org/10.1039/c7sc01647f |
Ejemplares similares
-
5-Bromo-norborn-2-en-7-one derivatives as a carbon monoxide source for palladium catalyzed carbonylation reactions
por: Payne, China M., et al.
Publicado: (2019) -
Enrichment-triggered Prodrug Activation Demonstrated through Mitochondria-targeted Delivery of Doxorubicin and Carbon Monoxide
por: Zheng, Yueqin, et al.
Publicado: (2018) -
Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells
por: McDougall, Lorissa, et al.
Publicado: (2021) -
Light‐Activated Carbon Monoxide Prodrugs Based on Bipyridyl Dicarbonyl Ruthenium(II) Complexes
por: Geri, Stepan, et al.
Publicado: (2020) -
Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules
por: De La Cruz, Ladie Kimberly, et al.
Publicado: (2021)